Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Anadys, Structural GenomiX Form Antibacterials Alliance

Feb. 21, 2002

By Aaron Lorenzo

Cytyc Acquiring Digene In Stock, Cash Deal Worth $554M

Feb. 20, 2002

By Aaron Lorenzo

Cytyc Acquiring Digene In Stock, Cash Deal Worth $554M

Feb. 20, 2002

By Aaron Lorenzo

Norak Closes Series B, Raises $13M For Screening Platform

Feb. 7, 2002

By Aaron Lorenzo

Chiron Licenses TB Product To Public-Private Partnership

Feb. 4, 2002

By Aaron Lorenzo

Biogen, Genaissance Align In Pharmacogenomics Area

Feb. 4, 2002

By Aaron Lorenzo

Biogen, Genaissance Align In Pharmacogenomics Area

Feb. 4, 2002

By Aaron Lorenzo

Chiron Licenses TB Product To Public-Private Partnership

Feb. 4, 2002

By Aaron Lorenzo

Intradigm, DirectGene Team Up To Develop Cancer Therapeutics

Jan. 28, 2002

By Aaron Lorenzo

Intradigm, DirectGene Team Up To Develop Cancer Therapeutics

Jan. 28, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 3, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.